Login / Signup

Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.

Jürgen Michael SteinAndreas WalperWolfgang KlemmKarima FarragAyşegül AksanAxel U Dignass
Published in: Scandinavian journal of gastroenterology (2018)
Iron isomaltoside was demonstrated to be effective and had a good safety profile in IBD patients in everyday clinical practice in Germany.
Keyphrases
  • iron deficiency
  • clinical practice
  • patients with inflammatory bowel disease
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • high dose